Published in Lab Invest on August 01, 1987
Role of microglial IKKbeta in kainic acid-induced hippocampal neuronal cell death. Brain (2008) 1.65
Intra- and extracellular amyloid fibrils are formed in cultured pancreatic islets of transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci U S A (1994) 1.13
Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease. Am J Pathol (1990) 1.06
Constitutive secretion of cystatin C (gamma-trace) by monocytes and macrophages and its downregulation after stimulation. J Exp Med (1987) 1.00
Ki-M1P as a marker for microglia and brain macrophages in routinely processed human tissues. Acta Neuropathol (1992) 0.81
Antiviral antibodies stimulate production of reactive oxygen species in cultured canine brain cells infected with canine distemper virus. J Virol (1989) 0.80
Cystatin C in aging and in Alzheimer's disease. Ageing Res Rev (2016) 0.75
The characterization of soluble amyloid prepared in water. J Clin Invest (1968) 6.17
Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science (1992) 5.22
Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest (2000) 5.07
Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science (1990) 4.71
Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell (1995) 4.32
Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett (1992) 4.29
Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nat Med (1998) 4.17
The amino acid sequence of a major nonimmunoglobulin component of some amyloid fibrils. J Clin Invest (1972) 3.96
The interaction of mycoplasmas with mammalian cells. I. HeLa cells, neutrophils, and eosinophils. J Exp Med (1966) 3.38
Studies on human platelet granules and membranes. J Clin Invest (1966) 3.22
Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers. Proc Natl Acad Sci U S A (1996) 2.79
The percentage of monocytes among "mononuclear" cell fractions obtained from normal human blood. J Immunol (1974) 2.69
Down patients: extracellular preamyloid deposits precede neuritic degeneration and senile plaques. Neurosci Lett (1989) 2.69
Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am J Pathol (1994) 2.66
The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex. Biochem J (1993) 2.66
Structural studies of immunoglobulin G. Nature (1969) 2.63
Variations in the S-S bridges of immunoglobins G: interchain disulfide bridges of gamma G3 myeloma proteins. J Mol Biol (1968) 2.57
A stop-codon mutation in the BRI gene associated with familial British dementia. Nature (1999) 2.46
Human amyloidosis, Alzheimer disease and related disorders. Lab Invest (1988) 2.44
The disulphide bonds of the heavy chain of rabbit immunoglobulin G. Biochem J (1970) 2.32
Alpha chain disease. Ann N Y Acad Sci (1971) 2.31
Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals. Neurosci Lett (1988) 2.26
Differences between vascular and plaque core amyloid in Alzheimer's disease. J Neurochem (1988) 2.24
HTLV tax and mycosis fungoides. N Engl J Med (1993) 2.23
In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease beta-protein. Biochem Biophys Res Commun (1986) 2.16
A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred. Proc Natl Acad Sci U S A (2000) 2.11
Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes. J Exp Med (1978) 2.09
Isolation and partial characterization of SAA-an amyloid-related protein from human serum. J Immunol (1976) 2.05
Apolipoprotein J (clusterin) and Alzheimer's disease. Microsc Res Tech (2000) 2.00
Fate of cerebrospinal fluid-borne amyloid beta-peptide: rapid clearance into blood and appreciable accumulation by cerebral arteries. J Neurochem (1996) 1.96
Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. Proc Natl Acad Sci U S A (1996) 1.94
The phagosomes in rheumatoid synovial fluid leukocytes: a light, fluorescence, and electron microscope study. Arthritis Rheum (1966) 1.93
The ultrastructure of lymphocytes. Semin Hematol (1969) 1.93
Preferential association of kappa IIIb light chains with monoclonal human IgM kappa autoantibodies. J Immunol (1983) 1.87
A 25-kDa NH2-terminal fragment carries all the antibacterial activities of the human neutrophil 60-kDa bactericidal/permeability-increasing protein. J Biol Chem (1987) 1.86
Association between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med (1977) 1.86
Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides. Biochem J (2000) 1.84
Primary structure of the "hinge" region of human IgG3. Probable quadruplication of a 15-amino acid residue basic unit. J Biol Chem (1977) 1.83
Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid. Biochem Biophys Res Commun (1993) 1.80
Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C). Proc Natl Acad Sci U S A (1986) 1.78
Current concepts of amyloid. Adv Immunol (1972) 1.75
Amyloid protein of Gerstmann-Sträussler-Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N-terminal glycine at codon 58. EMBO J (1991) 1.74
Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation. Biochem Biophys Res Commun (1996) 1.73
Nucleotide sequence of the small double-stranded RNA segment of bacteriophage phi 6: novel mechanism of natural translational control. J Virol (1986) 1.72
Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E. Biochem J (1995) 1.72
Substitutions at codon 22 of Alzheimer's abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells. J Biol Chem (2000) 1.71
The actin and myosin filaments of human and bovine blood platelets. J Clin Invest (1972) 1.71
Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis. Lab Invest (1988) 1.70
The submembranous fibrils of human blood platelets. J Cell Biol (1970) 1.70
Amyloid fibrils in Gerstmann-Sträussler-Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele. Cell (1994) 1.69
Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice. Am J Pathol (2001) 1.69
Physical, chemical, and ultrastructural studies of water-soluble human amyloid fibrils. Comparative analyses of nine amyloid preparations. J Exp Med (1969) 1.66
Partial deletion in the heavy chain disease protein ZUC. Nature (1969) 1.65
Insertion of influenza M protein into the viral lipid bilayer and localization of site of insertion. J Virol (1981) 1.65
Prion protein amyloidosis. Brain Pathol (1996) 1.64
Structural studies of human gamma-G-myeloma proteins of different antigenic subgroups and genetic specificities. J Exp Med (1966) 1.62
Apolipoprotein J and Alzheimer's amyloid beta solubility. Biochem J (1996) 1.61
Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta. Biochem Biophys Res Commun (1994) 1.60
Nomenclature of amyloid fibril proteins. Report from the meeting of the International Nomenclature Committee on Amyloidosis, August 8-9, 1998. Part 1. Amyloid (1999) 1.59
The interaction of mycoplasmas with mammalian cells. II. Monocytes and lymphocytes. J Exp Med (1966) 1.57
Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease. Proc Natl Acad Sci U S A (1987) 1.56
Antiidiotypic activity in the IgM fractions of mixed cryoglobulins. J Immunol (1980) 1.55
Amyloid fibril in hereditary cerebral hemorrhage with amyloidosis (HCHWA) is related to the gastroentero-pancreatic neuroendocrine protein, gamma trace. J Exp Med (1983) 1.55
Beta-2 microglobulin is an amyloidogenic protein in man. J Clin Invest (1985) 1.54
Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. J Clin Invest (1994) 1.54
Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides. Lancet (2000) 1.54
Characterization of apolipoprotein J-Alzheimer's A beta interaction. J Biol Chem (1995) 1.53
Clearance of amyloid beta-peptide from brain: transport or metabolism? Nat Med (2000) 1.53
Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. J Clin Invest (1998) 1.51
Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. Biochem Biophys Res Commun (1991) 1.51
Mutation in gelsolin gene in Finnish hereditary amyloidosis. J Exp Med (1990) 1.50
Immunochemical similarities between monoclonal antibacterial Waldenstrom's macroglobulins and monoclonal anti-DNA lupus autoantibodies. J Exp Med (1985) 1.49
Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. Am J Pathol (1998) 1.48
Blood-brain barrier transport of circulating Alzheimer's amyloid beta. Biochem Biophys Res Commun (1993) 1.48
Amyloidosis due to a mutation of the gelsolin gene in an American family with lattice corneal dystrophy type II. N Engl J Med (1991) 1.48
IgA proteases of two distinct specificities are released by Neisseria meningitidis. J Exp Med (1980) 1.47
Electron microscopic studies of human granulocytes: structural variations related to function. Semin Hematol (1968) 1.47
Biology of A beta amyloid in Alzheimer's disease. Neurobiol Dis (1997) 1.45
Elastase-type proteases on the surface of human blood monocytes: possible role in amyloid formation. J Immunol (1980) 1.45
Disulphide bridges of immunoglobin G-1 heavy chains. Nature (1967) 1.44
White cell reduction by filtration may significantly decrease human T-lymphotropic virus type 1 Tax sequences and Tax-encoded proteins in blood used for transfusion. Transfusion (1998) 1.44
Ten to fourteen residue peptides of Alzheimer's disease protein are sufficient for amyloid fibril formation and its characteristic x-ray diffraction pattern. Biochem Biophys Res Commun (1987) 1.44
Microfibrils of blood platelets: their relationship TO MICROTUBULES AND THE CONTRACTILE PROTEIN. J Clin Invest (1969) 1.43
Human rheumatoid factor cross-idiotypes. III. Bla monoclonal rheumatoid factor, prototype of the BLA cross-idiotype group, has distinct kappa chains related to the V kappa III subgroup and VH4 heavy chains. Arthritis Rheum (1990) 1.43
Primary structure of an amyloid prealbumin variant in familial polyneuropathy of Jewish origin. Proc Natl Acad Sci U S A (1983) 1.42
The majority of human monoclonal IgM rheumatoid factors express a "primary structure-dependent" cross-reactive idiotype. J Immunol (1985) 1.40
A variant of prealbumin from amyloid fibrils in familial polyneuropathy of Jewish origin. J Exp Med (1981) 1.39
Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci U S A (1995) 1.39
Idiotypic and subgroup analysis of human monoclonal rheumatoid factors. Implications for structural and genetic basis of autoantibodies in humans. J Clin Invest (1988) 1.38
Lymphocyte plasma membranes: analysis of proteins and glycoproteins by SDS-gel electrophoresis. Blood (1973) 1.38
Bence Jones proteins and light chains of immunoglobulins. Preferential association of the V lambda VI subgroup of human light chains with amyloidosis AL (lambda). J Clin Invest (1982) 1.37
Relationship between the specificity of IgA proteases and serotypes in Haemophilus influenzae. J Infect Dis (1982) 1.36
Common structural and antigenic properties of human gamma M anti-gamma globulins. J Immunol (1971) 1.36
Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein. Am J Pathol (1987) 1.36
Partial duplication in the "hinge" region of IgA 1 myeloma proteins. Proc Natl Acad Sci U S A (1972) 1.36
Electron microscopic study of isolated Kupffer cells. Am J Pathol (1969) 1.36
The partial amino acid sequence of the major low molecular weight component of two human amyloid fibrils. FEBS Lett (1972) 1.35
Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer's amyloid beta. J Neurochem (1997) 1.35
Alzheimer patients and Down patients: cerebral preamyloid deposits differ ultrastructurally and histochemically from the amyloid of senile plaques. Neurosci Lett (1989) 1.35